Israel - English - Ministry of Health

neopharm ltd, israel - obeticholic acid - film coated tablets - obeticholic acid 5 mg - obeticholic acid - ocaliva is indicated for the treatment of primary biliary cholangitis (also known as primary biliary cirrhosis) in combination with ursodeoxycholic acid (udca) in adults with an inadequate response to udca or as monotherapy in adults unable to tolerate udca.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

neopharma, united arab emirates - azithromycin - capsules - 250mg

Kenya - English - Pharmacy and Poisons Board

neopharma l.l.c. p.o. box 242462 - azithromycin 250mg - capsule, hard - 250mg - antibacterials for systemic use: macrolides

Israel - English - Ministry of Health

eisai israel ltd., israel - eribulin as mesilate - solution for injection - eribulin as mesilate 0.44 mg/ml - eribulin - eribulin - halaven is indicated for the treatment of adult patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimen for advanced disease. prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting unless patients were not suitable for these treatments.halaven is indicated for the treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease.

European Union - English - EMA (European Medicines Agency)

merck sharp dohme ltd - laropiprant, nicotinic acid - dyslipidemias - lipid modifying agents - trevaclyn is indicated for the treatment of dyslipidaemia, particularly in patients with combined mixed dyslipidaemia (characterised by elevated levels of low-density-lipoprotein (ldl) cholesterol and triglycerides and low high-density-lipoprotein (hdl) cholesterol) and in patients with primary hypercholesterolaemia (heterozygous familial and non-familial).trevaclyn should be used in patients in combination with 3-hydroxy-3-methyl-glutaryl-co-enzyme-a (hmg-coa)-reductase inhibitors (statins), when the cholesterol-lowering effect of hmg-coa-reductase-inhibitor monotherapy is inadequate. it can be used as monotherapy only in patients in whom hmg-coa-reductase inhibitors are considered inappropriate or not tolerated. diet and other non-pharmacological treatments (e.g. exercise, weight reduction) should be continued during therapy with trevaclyn.

Israel - English - Ministry of Health

neopharm ltd, israel - bimekizumab - solution for injection - bimekizumab 160 mg / 1 ml - bimekizumab - bimzelx ® is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.

Israel - English - Ministry of Health

neopharm (israel) 1996 ltd - sennae folium - tea - sennae folium 75 % - senna glycosides - senna glycosides - laxative.

Israel - English - Ministry of Health

neopharm ltd - polidocanol; soya oil - solution - soya oil 82.95 g / 100 g; polidocanol 15 g / 100 g - polidocanol - polidocanol - refatting medical oil bath with antipruritic effect.

Israel - English - Ministry of Health

neopharm ltd - erythromycin; tretinoin - solution - erythromycin 4 g / 100 g; tretinoin 0.025 g / 100 g - erythromycin, combinations - erythromycin, combinations - all forms of acne, both non-inflammatory forms with comedones and inflammatory forms with papules and pustules, particularly in the case of fat-rich skin.

Israel - English - Ministry of Health

neopharm ltd - azacitidine - lyophilized powder for suspension for sc injection / solution for infusion - azacitidine 100 mg/vial - azacitidine - azacitidine - for the treatment of patients with the following fab myelodysplastic syndromes subtypes: refractory anemia or refractory anemia with ringed sideroblasts ( if accompanied by neutropenia or thrombocytopenia or requiring transfusions),refractory anaemia with excess blasts, refractory anaemia with excess blasts in transformation, and chronic myelomonocytic leukaema.